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Abstract:  
Background: Biomedical devices and implants are adversely affected by biofilm-
associated infections that pose serious public health issues. Biosurfactants (BSs) can combat 
pathogenic biofilms through their antimicrobial, antibiofilm and antiadhesive capabilities. The 
objective of our research was to produce biosurfactant (BS) from Lactobacillus acidophilus 
NCIM 2903 and investigate its antibiofilm potential using microfluidics strategies by mimicking 
the micro-environment of biofilm.  
Methods: Antibiofilm and antiadhesive potential was effectively evaluated using different 
methods like microfluidics assay, catheter assay, polydimethlysiloxane (PDMS) disc assay. 
Along with this chemical and physical characteristics of BS were also evaluated. 
Results: Cell free biosurfactant (CFBS) obtained was found to be effective against 
biofilm which was validated through the microfluidic or Lab on Chip (LOC) approach. The 
potency of CFBS was also evaluated on catheter tubing and PDMS surfaces (representative 
bioimplants). The efficacy of CFBS was also demonstrated through the reduction in surface 
tension, interfacial tension, contact angle and low critical micelle concentration.  
Conclusion: CFBS was found to be a potential antimicrobial and antibiofilm agent. We 
believe that perhaps this is the first report on demonstrating the inhibiting effect of Lactobacillus 
spp. CFBS via LOC approach. These findings can be explored to design various BSs based 
formulations exhibiting antimicrobial, antibiofilm and antiadhesive potential for biomedical 
applications. 
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1. Introduction 
Medical devices and equipment are routinely used by most healthcare professionals to support 
and treat the patients. Bioimplants are amenable to develop microbial biofilms. Biofilms are 
microbial communities with abilities to attach to surfaces, exhibiting high resistance to many 
antimicrobial agents [1-6]. Pathogenic microbial biofilms exert harmful effects on human health. 
Increased resistance of bacteria to antibiotic therapy is a major concern for medical professionals 
worldwide. The inherent resistance of biofilms and their pervasive involvement in implant-
related infections has prompted research towards the development of antibiofilm, antiadhesive 
agents. Biosurfactant (BS) producing microorganisms can disrupt biofilm on medical implants 
due to their antimicrobial, antibiofilm and antiadhesive potential. Lactic acid bacteria (LAB), 
such as Lactobacilli constitute an important part of the natural microbiota and are recognized as 
potentially useful bacteria through production of BSs [1-2,6]. Reports by Gomaa [7], Gudiña and 
co-workers [8-10] suggested that Lactobacilli originated BS is highly effective against several 
pathogenic microorganisms with distinct antimicrobial and anti-adhesive activities. Based on 
structural details, different types of BSs viz. Glycolipid [5,6], glycoprotein [8,11], 
glycolipoprotein/peptide [12,13] have been documented from Lactobacillus spp. and are 
therefore considered to be promising agents in tackling biofilms associated infections [7,8,11]. 
Lactobacilli spp. are solely known to produce cell bound/cell associated BS (CABS) and cell free 
BS (CFBS) [14]. BS mediated synthesis of nanoparticles (NPs) is becoming an interesting 
approach for many researchers [15]. Currently, several researchers are synthesizing metal NPs 
from microbial origin and exploiting them for biomedical purposes [16,17]. Reddy et al., [18, 19] 
reported synthesis of silver and gold NPs by using fractionated BS (as a stabilizer) with 
NaBH4 (as a reducing agent). BS plays a crucial role in the synthesis of gold and silver NPs from 
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B. subtilis ANR 88 by growing in non-hydrocarbon, agro industrial wastes.  Synthesis of uniform 
size and shapes silver NPs (spherical, 4–18 nm) and gold (hexagonal, 40–60 nm) from BS 
producing Bacillus culture has been achieved [20]. Inspiring discoveries or novel formulations 
introduced by the engineering sector have improved our modern life. Currently incredible 
applications in the areas of protein crystallization, biochemical screening [21], DNA 
amplification, DNA sequencing and enzymatic kinetic assays [22] are driving forces to explore 
advanced developments of engineering. Microfluidics (MF) is one of the pioneering areas of 
engineering that deals with pico litre volumes of liquids [23]. MF terminology is popularly 
known as lab-on-a-chip (LOC) where experiments are carried out on small scale in-vitro, 
mimicking in-vivo conditions [24]. MF devices have been reported to characterize cellular 
association in a flow system. Recently, Khor et al., 2018 [25] have cultured HUVECs on the 
surface of synthetic micro-vascular network in a MF device (SynVivo, INC). This study 
provided an opportunity to explore possible interactions of molecules with live cells. MF devices 
with simple and straight microchannels may not be sufficient to replicate the complex structures 
of the desired systems. However, to some extent MF system are helpful in exploring interactions 
between nanoparticles with biological molecules. Implementation of fundamental experiments, 
applied, analytical and diagnostic are often very challenging to carry out due to the availability of 
compounds in negligible quantities. MF system offers better prospects to overcome these 
challenges and assist medicinal and therapeutic perspectives. It is also important to highlight that 
the monetary inputs along with labour cost are also reduced. Automation in the experimental set 
up facilitates the different combinations for experimental purposes [26]. 
The advantage of MF set up is that the experiments can be minimized so that extremely sensitive 
methods can be amalgamated. The design of this innovative technique promotes elucidating the 
5 
 
unexplored biological and diagnostic challenges. Some BS related investigations are quite 
challenging due to the limited amount of BS produced for in-vitro studies. In this study we report 
the production, physic-chemical characterization of CFBS from Lactobacillus spp., some of the 
physical aspects of CFBS such as surface tension (SFT), critical micelle concentration (cmc), 
interfacial tension (IFT), contact angle (CA) and ionic character.  In addition the properties of BS 
like antimicrobial, antiadhesive and antibiofilm have been explored against pathogenic bacteria 
on catheter tubing and PDMS based bioimplant surfaces. To the best of our knowledge, this is 
the first report that describes the functional properties of Lactobacillus derived BS using MF 
approaches.  
 
2. Experimental 
2.1 Microbial cultures 
L. acidophilus NCIM 2903 used for BS production was obtained from the National Collection of 
Industrial Microorganisms (NCIM), National Chemical Laboratory (NCL), Pune, Maharashtra, 
India. To visualize the effect of BS on microbial biofilms, bacterial cultures viz., Escherichia 
coli NCIM 2065, Staphalococcus aureus NCIM 2079, Proteus vulgaris NCIM 2027 were 
obtained from NCIM, NCL. Other cultures, Bacillus subtilis MTCC 2423, Pseudomonas putida 
MTCC 2467 and P. aeruginosa MTCC 2297 were obtained from Microbial type culture 
collection (MTCC), Chandigarh, India. All cultures were grown and maintained as per supplier’s 
instructions. 
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2.2 Biosurfactant production and extraction  
Fermentation medium (FM) used for production of CFBS was described in our recent 
communications [1]. To extract BS, cell free supernatant (CFS) was obtained by centrifuging the 
culture broth after 72 h at 15,000 rpm/20 min/4 °C and was acidified using 5 N HCl to bring 
down the pH (from 8.9 to 2.0). Further CFS was kept overnight at 4 °C for precipitation of BS 
under acidic condition and further it was extracted with ethyl acetate and methanol (4:1) mixture. 
The organic layer was collected and anhydrous ammonium sulphate was added to remove the 
water content. Further, organic layer was evaporated to dryness using rotary evaporator [27], and 
was purified by column chromatographic technique [5,6]. 
 
2.3 Determination of physical and chemical properties  
Physical properties including SFT, IFT, CA, cmc, emulsification, stability at different pH, 
temperature and ionic character were explored for L. acidophilus NCIM 2903 derived CFBS. 
SFT, IFT, cmc measurements were carried out by pendant drop technique, while CA using 
sessile drop technique with the help of optical contact angle (OCA) Goniometer [28]. In 
addition; ionic character (IC), emulsification activity (%) was also determined. To find out the 
emulsification activity of CFBS; 2 ml of hydrocarbon (kerosene, n-decane, n-hexane, xylene, 
benzene and n-heptane) was vigorously mixed with an equal volume CFBS solution (cmc 
solution). For positive control the cmc solutions of four synthetic surfactants (SDS, CTAB, 
Tween 80, AOT) were included. The mixture of each hydrocarbons and surfactants were mixed 
thoroughly by voxtexing 2 min/RT (30 °C)/1 h [15]. Immediate after mixing and settling down at 
RT, both the relative emulsion volume (REV, %) and the emulsion stability (ES, %) were 
measured at zero hour and after 24 h [29]. The stability of CFBS at different temperatures (4, 30, 
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60 to 121 °C) and pH (ranging between 2 to 14) were examined. Agar double diffusion 
technique was carried out to determine the ionic character of CFBS [30]. Two regularly-spaced 
rows of wells were punched in a soft agar (1% w/v). The upper row was filled with reference 
surfactants (with known ionic character) in around 20 mM concentration (SDS, AOT, CTAB, 
barium chloride) and lower row was filled with BS (10 mg/ml) and allowed to diffuse at RT. The 
set up was monitored on 4 h intervals for 48 h to detect formation of a line of precipitation 
between cationic and anionic pair.  
Chemical characterization of CFBS was carried out via thin layer chromatography (TLC) and 
Fourier-transform infrared (FTIR) spectroscopy to demonstrate the presence of functional groups 
[1]. Rhamnolipid (RHL) BS (Agae, Technologies, USA) was considered as a reference 
compound for both TLC and FTIR analysis. Different solvent systems and developers were used 
to detect presence of sugar and lipid moieties on pre-coated silica gel plates (Merck, India). The 
presence of UV active spots of CFBS was confirmed under UV light [5,6,11]. For FTIR analysis 
of CFBS, ~ 1 mg of CFBS paste was grounded with 100 mg of KBr. The translucent pellet was 
analysed by FTIR device (Jasco FT/IR-6100, Japan). The spectrum ranging between 400–
4000 cm−1 at a resolution of 4 cm−1 was analyzed.  
 
2.4 Determination of antimicrobial, antiadhesive properties 
Micro-dilution technique in 96-well ﬂat-bottom plastic tissue culture plates (Greiner Bio-One 
GmbH, Frickenhausen, Germany) was carried out to determine the antimicrobial and 
antiadhesive activity of CFBS compound (625 µg/ml) against six test bacterial cultures as 
described by Gudiña et al., [8-10] and Satpute et al., [1].  
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2.5 Preparation of microfluidics (MF) assembly 
Polydimethylsiloxane (PDMS) based MF channels were designed by mixing elastomer and 
curing agent (Elastomer solution kit: 184 Sylgard, Dow Corning, USA) in a ratio 10:1 (w:w).  
This solution was mixed thoroughly and then bubbles were removed by placing this solution in 
vacuum desiccators until a clear solution was achieved. This bubble free and clear solution was 
poured on Si wafer containing impression of rectangular micro-channels with width 200 µm and 
height 100 µm. While pouring the PDMS liquid, care was taken to prevent the formation of any 
cracks and minimize air entrapment. It was allowed to solidify at a temperature of 80-100 °C for 
6 h in a vacuum oven at a pressure of 100 Pa (10-3 to 1 Torr). Mixing process commences the 
curing reaction that is evident from the gradual increase in viscosity of the solution resulting in 
gelation and finally altering as a solid elastomer.  
After completion of the solidification process, the MF chambers were cut in the shape of typical 
glass slide size (7.5 cm length and 2.5 cm wide). PDMS liquid was layered on a clean, grease 
free glass slide and MF chamber (previously cut) were placed on the glass slide. In this way the 
MF chamber channels were sealed at the bottom. The MF assembly preparation was allowed to 
solidify at 50-60 °C overnight after which, the MF channels were ready to use use. Loading of 
the medium, sample and reagents was carried out using a Hamilton precision syringe (500 µl). In 
this case the flow rate of the reagents was not crucial as the method involved CFBS coating on 
the inner side of the MF channel. As shown in the Figure 1, the sample was loaded from the 
loading point (A) until it overflowed from the sample exit (B) point to ensure the complete 
filling/coating of MF channels. At this stage the ‘LOC’ device was ready for further 
experimental purpose to visualize the in-vivo condition in the laboratory. Around 2 µl sample is 
loaded in the MF channels which takes 3 seconds to coat the channels completely. The total 
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length of the MF channel was 2.0 cm with a PDMS thickness of 0.2 cm and a diameter of hole 
(sample loading and exit points) is 1 mm. The channel width was 200 µm with a height of 100 
µm. Figure 1. illustrates the actual construct of MF system used to conduct the experiment. 
 
A
B
4 mm
 
Figure 1. Microfluidics model used to conduct Lab on Chip assay. A: Sample loading point; B: 
Sample exit point after filling the MF channels completely. 
 
2.6 Preparation of polydimethylsiloxane (PDMS) surface 
The procedure used for preparation of PDMS based surface is described in the section 2.5. The 
clear solution of PDMS was poured in sterile disposable petri dish and after solidification at 50-
60 °C for 1 h, circular PDMS disc (diameter 0.8 cm and thickness of 0.1 cm) were cut. Sterile 
discs were coated (4 °C/overnight) with sterile CFBS (625 µg/ml - cmc solution) to analyze its 
inhibiting effect on bacterial biofilm. Other set of disc coated only with PBS (without any CFBS) 
were considered as control. All discs were immersed in sterile culture medium inoculated with 
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test cultures and incubated at 37 °C for 48 h. Further discs were removed and rinsed with sterile 
distilled water and scanning electron microscopic (SEM) images were taken.  
 
2.7 Foley catheters assay 
Biofilm formed in catheters were visualized as per assay described by Mireles et al., [31]. In 
brief about 10 μl of overnight bacterial culture (0.5 McFarland standard) was inoculated into 500 
μl of medium and injected into 2 cm long clear sterile silicone based urethral catheters (Poly 
Medicure suction catheter, India). The catheter tubes were capped at both ends and incubated at 
37 °C for 48 h. Media and growth conditions were followed as per instructions provided by 
suppliers. This experimental set up were considered as control and other parallel set was first 
coated with glycolipid CFBS (625 µg/ml) and left at 4 °C for overnight and then the above 
procedure was continued. After 48 h cultures were removed from the catheter (control and test) 
and OD630 nm was determined followed by rinsing the catheters with distilled water and further 
dried at RT for 15 to 20 min. After completing the air drying procedure, ~500 μl of crystal violet 
(CV) (1% w/v) were added in all catheter tubing and left at RT for 20 min. All biofilms 
developed on catheters appeared purple due to the CV staining. Further, excess stain of CV was 
removed by washing with distilled water for several times and catheter tubes were examined for 
the presence of biofilms. 
 
3. Results  
The recurrence of infective diseases and the endless advancement in antibiotic resistance among 
disease-causing microbes has become one of the greatest threats to human health [32]. This kind 
of resistance has developed due to the ability of these microorganisms to form a biofilm on 
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various surfaces where microorganism can shelter. BSs do possess some properties of significant 
therapeutic potential reflected through anti-microbial, anti-biofilm and anti-adhesive potentials. 
LAB has been recognized for BS production and beneficiary impact on human system [14]. 
Among LAB, Lactobacilli spp. have a highly competitive nature in gastrointestinal tract (GIT) 
by preventing the growth and adherence of pathogens. Consequently, in the current study we 
explored antibacterial anti-biofilm and anti-adhesion property of BSs derived from L. 
acidophilus. 
 
3.1 Production and extraction of biosurfactant 
In this paper, we used a comparatively simpler medium for synthesis of CFBS. Reduction in the 
SFT of CFBS with change in pH indicated the production of CFBS by strain NCIM 2903. In 
addition, gradual increase in the diameter of the drop of CFS on parafilm surface demonstrated 
the production of CFBS. MRS medium was found to be more appropriate for growth of NCIM 
2903 culture but not for reducing the SFT of CFS. Therefore, FM was considered as a better 
medium for the production of BS throughout the experiment. CFS collected after 72 h of 
incubation found to be suitable for extraction of CFBS. Further purification through column 
chromatography using chloroform:methanol (60:40) yielded 1.5 g/L of BS.  
 
3.2 Analysis of physical and chemical properties of biosurfactant 
Analysis of physical properties like SFT, IFT, cmc, CA, emulsification properties and ionic 
character proved the effectiveness of CFBS. The SFT of PBS was reduced from 72 to 27 mN/m 
with a cmc 625 µg/ml (Figure 2A). Figure 2B represents the semi-logarithmic reflection of the 
same cmc value from SFT versus CFBS concentration.  
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Figure 2. (A) Variation in surface tension and (B) semi-logarithmic reflection of critical micelle 
concentration (cmc) value from SFT (mN/m) versus CFBS concentration for derived from NCIM 
2903. 
 
Other physical properties like IFT, CA, EA, ES also confirmed the efficacy of CFBS produced 
by NCIM 2903 with great certainty. The IFT measurements with immiscible liquids 
(hydrocarbons), showed lowest IFT against benzene (1.47 mN/m) followed by kerosene, o-
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xylene, n-hexane (Figure 3). There was good reduction in IFT values by CFBS against all 
hydrocarbons tested in comparison to other synthetic surfactants.  
 
Figure 3. Measurement of interfacial tension (IFT) mN/m for CFBS obtained from L. 
acidophilus NCIM 2903 and synthetic surfactants against water insoluble liquids. Control: 
Phosphate buffer saline; CFBS: Cell free biosurfactant; AOT: Aerosol OT; CTAB: cetyl 
trimethyl ammonium bromide; SDS: sodium dodecyl sulphate.  
 
Effective spreading abilities for CFBS were tested through the measurement of CA. The highest 
reduction in CA was observed on polystyrene (From θ= 90° to 49°) and PDMS (from θ =115° to 
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74°) followed by Teflon (from θ =115° to 75°).  Polystyrene and PDMS surfaces are used 
regularly in biomedical industries. CA on OHP transparent sheet was reduced from θ = 69° to 
44°. However, on the highly hydrophilic glass surface; there was no significant reduction in CA 
values (from θ = 39° to 25°) (Figure 4).   
 
Figure 4. Measurement of contact angle (CA) (degrees) for CFBS obtained from L. acidophilus 
NCIM 2903 on different surfaces, OHP: Overhead Projector Transparent sheet; PDMS: 
polydimethlysiloxane. 
The CA measurements for CFBS derived from Lactobacillus sp. have seldom been reported in 
literature.  The emulsification capacity and stabilization activity of CFBS against different water 
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insoluble liquids analysis showed that CFBS has relative EV between 25-65% and ES between 
45-87% after 24 h. The highest EV (65%) was seen against n-decane with 87% of ES. CFBS 
demonstrated good EV (46%) and ES (87%) with xylene. Treatment of CFBS (cmc solution) at 
different pH (2.0 to 12.0) indicated higher stability between the pH of 6-10 and lowest SFT value 
at pH 7.0 indicating the potency of CFBS at neutral to alkaline conditions rather than acidic 
conditions. However, treatment of acidic pH result the precipitation of CFBS. Regarding the 
temperature effects, CFBS worked well at different temperatures (4, 30, 70 and 121 °C). 
Determination of ionic character by agar double diffusion technique indicated passive diffusion 
between CTAB (cationic compounds) and CFBS proving the presence of anionic charge on 
CFBS (Figure 5). A prominent line of precipitation formed on soft gel helped rapid 
determination of ionic character of CFBS.  
 
Figure 5. Double diffusion of cationic surfactant (B) (positively charged) CTAB against CFBS 
(A) on agar plate indicating a line of precipitation due to formation of ionic pair. 
Sugar and lipid moieties were detected using TLC confirming the presence of glycolipid typed 
CFBS. The chemical composition was confirmed by FTIR analysis (Figure 6).  
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Figure 6. FTIR spectrum for CFBS obtained from L. acidophilus NCIM 2903.  
 
The peak at 3320 cm-1 depicts the presence of OH stretching. The presence of hydrocarbons is 
confirmed by the peak at 2900 cm-1. The peaks at 1730 cm-1 significantly denote the presence 
C=O stretching in ester bond. The presence of ether moiety was confirmed by the presence of 
peak at 1230 while the presence of sugar moiety was clearly indicated by the peak at 1000 cm-1 
(C-O stretching in sugars). The results of our study strongly suggest a glycolipid nature of CFBS.  
 
3.3 Antimicrobial, antiadhesive and antibiofilm potential of biosurfactant   
Our studies showed good antimicrobial, antiadhesive and antibiofilm potential of CFBS. It could 
be clearly seen in Figure 7 that CFBS exhibited antimicrobial activity ranging between 65 to 
87% against all bacterial strains used in the study. At the concentration of 625 µg/mL, it 
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inhibited the growth of S. aureus (87%), P. aeruginosa (85%), B. subtilis (82%) and followed by 
E. coli (80%) and Ps. putida and P. valgaris (70%).  
 
Figure 7. Antimicrobial potential of CFBS (625 µg/ml) derived from NCIM 2903 against P. 
aeruginosa MTCC 2297, P. putida MTCC 2467, B. subtilis MTCC 2423, E. coli NCIM 2065, P. 
vulgaris NCIM 2027 and S. aureus NCIM 2079. 
 
 
3.4 Investigation of antiadhesive and antibiofilm potential of CFBS via microfluidic 
approaches  
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The MF assembly shown in Figure 1 was used to investigate the antiadhesive and antibiofilm 
effect of CFBS against B. subtilis. Biofilms were observed at different locations of the MF 
channels without any coating of CFBS. No noticeable effects were seen in the control treatments 
of PBS which was evident by the high growth and viability of the test culture (Figures. 8A, B, 
C). The MF assembly coated with CFBS showed clear channels after staining with CV indicating 
that coating with CFBS inhibited the adhesion and biofilm formation on the surface (Figure. 8D, 
E, F).  
A B
D
C
E F
400 µm
400 µm 400 µm 400 µm
400 µm400 µm
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Figure 8. Optical microscopic images of microfluidics (MF) assembly and biofilms on 
polydimethylsiloxane (PDMS) surfaces with (Test- Lower row D, E, F) and without (Control- 
Upper row A, B, C) CFBS coatings (625 µg/ml). In absence of CFBS coating, no inhibition of 
adhesion and therefore biofilm formation by B. subtilis (A, B, C) occurred. White coloured 
circles indicates the biofilm stained with crystal violet (1%) solution. In contrast, the test MF 
channels (D, E, F) are seen clear without biofilms. 
 
3.5 Biofilm formation on PDMS surface 
In addition to MF based approach, PDMS surfaces were also used to demonstrate the inhibiting 
effect of CFBS against biofilms formed by B. subtilis MTCC 2423, P. valgaris NCIM 2027. We 
used SEM technique to distinguish the conglomerations of biofilms on PDMS surfaces. 
Under SEM, Figures. 9: A, C (Control) where confluent biofilms were clearly visualized than in 
Figures. 9: B, D (Test) representing the CFBS pre-coated PDMS discs. Formation of microbial 
biofilms was restricted on surfaces of PDMS disc when they were previously coated with CFBS.  
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 Figure 9. SEM images of polydimethylsiloxane (PDMS) disc with (A, C) and without 
biofilms (B, D) of two bacterial cultures. The upper row (A and B) represents for B. subtilis 
MTCC 2423 and lower row (C and D) represents for P. valgaris NCIM 2027. Figure A and C 
represents the control surfaces indicating the PDMS disc without any CFBS coating where 
confluent growth of biofilms is seen. Whereas, Figure B and D represents the test surfaces 
indicating pre-coating with CFBS that inhibited the adherence and growth of bacteria proving the 
antibiofilm and antiadhesion potential of CFBS. 
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3.6 Foley catheter assay  
A commercially used medical grade catheter was also tested to explore the effect of CFBS on 
pathogenic bacterial biofilms. Figure 10A shows dark blue colouration due to the staining of 
biofilms formed by P. vulgaris NCIM 2027. Whereas Figure 10B did not show any blue colour 
development on catheter surface indicating that glycolipid CFBS inhibited the formation of 
biofilm of P. vulgaris NCIM 2027.  The pre-coated of silicone urethral catheters with glycolipid 
CFBS completely inhibited the adherence and growth of P. vulgaris NCIM 2027.  
 
Figure 10. Foley catheters assay: Inhibition of biofilm formed by P. vulgaris NCIM 2027 by 
CFBS on urethral catheters. A: The control where bacterial biofilm appears as a dark blue colour. 
B: The test, showing anti-biofilm property of CFBS against the bacterial strain. Development of 
biofilm was diminished absolutely on test catheter tubing. 
 
4.  Discussion 
4.1  Production and extraction of biosurfactant 
A             B 
22 
 
Most of the literature documented the use of de man Rogosa Sharpe (MRS) medium [33] for the 
synthesis BS from LAB including Lactobacilli spp. [1,14,34]. We have documented the lowest 
SFT value as 26 mN/m for FM observed after the growth of NCIM 2903 [1]. 
 
4.2  Analysis of physical and chemical properties of biosurfactant 
Physical properties viz., SFT, cmc, IFT, CA, emulsification clearly proved the potency of CFBS. 
We observed the maximum reduction in SFT of PBS from 72 to 27 mN/m at a cmc value of 625 
µg/ml (Figure 2A). In addition, noticeable reduction in CA on various surfaces and IFT values 
against various hydrocarbons entirely proved the potency of CFBS isolated in the present studies. 
It is important to note that the CA measurements of CFBS isolated from Lactobacillus sp. were 
rarely reported in literature. The emulsification with n-decane, and xylene was observed to be 
comparatively better. Our results are comparable with the Moldes et al., [13] for emulsions of 
octane/water stabilized by BS isolated from L. pentosus and SDS. Along with these results; the 
stability of BS at a wide physiological condition would contribute towards broadening its scope 
as antibiofilm agent. Our studies revealed the anionic nature of the CFBS. Similar results were 
reported by Sharma et al., [35] for the BS isolated from Enterococcus faecium. Structural 
examination of CFBS confirmed the glycolipid type. Closer observation in literature, we can say 
that our results are comparable with that of the work reported by Sharma et al., [5,6] who 
suggested the Xylolipidic type BS from Lactobacillus spp. In the literature, there are some 
instances, where researchers have claimed the production of glycolipid type BS from 
Lactobacillus sp. [5,6].  
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4.3  Antimicrobial, antiadhesive and antibiofilm potential of biosurfactant 
Several microorganisms have been used for a wide range of BS production some of which with 
some antimicrobial properties [3-4,7,11]. However, limited number of reports documented 
antimicrobial activity of BS obtained from Lactobacilli spp. CFBS obtained from few 
Lactobacilli spp, displayed antimicrobial activity at low concentrations [14]. The CABS are 
popular for their antiadhesive property rather than antimicrobial potential (concentration ranging 
between 4 to-50 mg/ml) [11]. In this work we have demonstrated antimicrobial activity of CFBS 
at a concentration of 625 µg/mL. More than 80% antimicrobial effect of CFBS were observed by 
the test organisms (S. aureus, P. aeruginosa, B. subtilis and E. coli) used in this study. Gudiña et 
al., [9] showed 76.8% antiadhesive activity at a 50 mg/ml of CABS isolated from L. paracasei 
spp. paracasei A20 against S. aureus.  
The growth of bacteria like E. coli ATCC and Y. enterocolitica were inhibited at a 
concentration of 25 mg/ml for CABS isolated from L. plantarum CFR 2194. The same 
surfactant at both concentrations was found to be ineffective against S. typhi. The possible 
mode of action of CFBS needs thorough investigation. BS can act on microbial system through 
interfering with the membrane functions and energy generating mechanisms. BS can reduce the 
cell surface hydrophobicity and microbial adherence to surfaces. Thus, microbial colonization 
can be prevented or reduced. BS can also increase the cell permeability and can cause the 
leakage of the metabolites. Alteration in physical membrane structure as well as interference of 
the protein conformations were also usually reported [4]. 
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4.4  Investigation of antiadhesive and antibiofilm potential via microfluidic approaches  
 To the best of our knowledge, this is perhaps the first report of MF based studies to demonstrate 
the inhibitory effect of Lactobacillus derived glycolipid CFBS against bacterial biofilms. CFBS 
inhibiting the adherence, growth and biofilm formation of pathogens is significant. Similar 
observations have been put forward by De Rienzo et al., [36] indicating the effect of 
sophorolipid (SPL) on B. subtilis using BioFlux channel system. The authors also suggested that 
multidrug-resistant bacterial infections can be reduced with the help of combinations of RHL and 
SPL.  
 
4.5 Biofilm formation on PDMS surface 
The BS strongly inhibited the biofilm formation on PDMS surface. Our results are comparable to 
studies carried out by Velraeds et al., [37] who showed inhibitory effect of CFBS produced by 
Lactobacillus sp on E. faecalis biofilms on glass surfaces. Our work also gave a strong indication 
towards the high capability of CFBS to act as antiadhesive and antibiofilm agents against 
pathogens. 
 
4.6   Foley catheter assay 
Our results obtained for silicon based urinary catheter are comparable with Rivardo et al., [38], 
who showed that BSs of Bacillus spp. inhibits biofilm formed by E. coli and S. aureus. Similarly, 
Irie et al., [39] also displayed biofilm dispersion ability of P. aeruginosa originated RHL against 
Bordetella bronchiseptica. BS molecules can work excitingly in synergistic way (against 
pathogens) in association with antibiotics, NPs etc. Gómez-Graña et al., [40] suggested that the 
CFBS exhibit deep impact in reducing the metal precursor and also stabilizing the NPs. More 
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importantly BS stabilized NPs exhibit the antimicrobial properties against various well known 
pathogens like E. coli, P. aeruginosa, S. aureus. Such evidence reflects the broad spectrum 
potential of BS mediated NPs for tackling the antimicrobial resistance. Promising experimental 
procedures are mandatory for synthesis of NPs where Green technology is the major driving 
force for the researchers. Currently nanotechnology is in an attempt to use clean, non-toxic and 
eco-friendly to synthesize nanomaterials in order to minimize the disposal of wastes. Microbes 
are popularly known for synthesis of inorganic molecules which can be deposited intra or outside 
the cells [15]. Use of nanomaterials amalgamated with extraordinary molecules like BS, 
antibiotics definitely provides opportunities to explore the innovative applications. 
 
5. Conclusions  
Glycolipid BS displayed virtuous antimicrobial, anti-adhesion and anti-biofilm potential against 
pathogenic bacteria on catheters and PDMS surfaces. MF confirms its ability to restrict the 
primary adhesion of biofilm forming pathogenic bacteria on surfaces. These studies are 
noteworthy to be widely used to examine biofilm cohesion under a variety of physiological like 
temperature and pH. CFBS may have commercial applications for several medical devices in 
prolonging the life of some biomaterials as well as reduce the possibilities of opportunistic 
infections. It is possibly the first time that MF system were used to demonstrate the antibiofilm 
effect CFBS derived from Lactobacillus spp. This simple technique can be used for testing 
various antibiofilm and antiadhesive formulations against various pathogens at laboratory level. 
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